Literature DB >> 27365298

Early Activation of Experience-Independent Dendritic Spine Turnover in a Mouse Model of Alzheimer's Disease.

Jacqueline K Heiss1,2, Joshua Barrett1, Zizi Yu1, Laura T Haas1, Mikhail A Kostylev1, Stephen M Strittmatter1,3,4.   

Abstract

Synaptic loss is critical in Alzheimer's disease (AD), but the dynamics of synapse turnover are poorly defined. We imaged dendritic spines in transgenic APPswe/PSen1∆E9 (APP/PS1) cerebral cortex. Dendritic spine turnover is increased far from plaque in aged APP/PS1 mice, and in young APP/PS1 mice prior to plaque formation. Dysregulation occurs in the presence of soluble Aβ oligomer and requires cellular prion protein (PrPC). APP/PS1 mice lack responsiveness of spine turnover to sensory stimulation. Critically, enhanced spine turnover is coupled with the loss of persistent spines starting early and continuing with age. To evaluate mechanisms of experience-independent supranormal spine turnover, we analyzed the transcriptome of young APP/PS1 mouse brain when turnover is altered but synapse density and memory are normal, and plaque and inflammation are absent. Early PrPC-dependent expression changes occur in synaptic and lipid-metabolizing genes. Thus, pathologic synaptic dysregulation underlying AD begins at a young age prior to Aβ plaque.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer; dendritic spine; plasticity; prion protein; somatosensory cortex

Mesh:

Substances:

Year:  2017        PMID: 27365298      PMCID: PMC6059166          DOI: 10.1093/cercor/bhw188

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  78 in total

1.  Memory impairment in transgenic Alzheimer mice requires cellular prion protein.

Authors:  David A Gimbel; Haakon B Nygaard; Erin E Coffey; Erik C Gunther; Juha Laurén; Zachary A Gimbel; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

2.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

3.  Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques.

Authors:  Robert M Koffie; Melanie Meyer-Luehmann; Tadafumi Hashimoto; Kenneth W Adams; Matthew L Mielke; Monica Garcia-Alloza; Kristina D Micheva; Stephen J Smith; M Leo Kim; Virginia M Lee; Bradley T Hyman; Tara L Spires-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-19       Impact factor: 11.205

4.  Long-term sensory deprivation prevents dendritic spine loss in primary somatosensory cortex.

Authors:  Yi Zuo; Guang Yang; Elaine Kwon; Wen-Biao Gan
Journal:  Nature       Date:  2005-07-14       Impact factor: 49.962

5.  Synaptic plasticity defect following visual deprivation in Alzheimer's disease model transgenic mice.

Authors:  Christopher M William; Mark L Andermann; Glenn J Goldey; Demetris K Roumis; R Clay Reid; Carla J Shatz; Mark W Albers; Matthew P Frosch; Bradley T Hyman
Journal:  J Neurosci       Date:  2012-06-06       Impact factor: 6.167

6.  Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model.

Authors:  Tara L Spires-Jones; Melanie Meyer-Luehmann; Jennifer D Osetek; Phillip B Jones; Edward A Stern; Brian J Bacskai; Bradley T Hyman
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

7.  Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.

Authors:  Erika Chung; Yong Ji; Yanjie Sun; Richard J Kascsak; Regina B Kascsak; Pankaj D Mehta; Stephen M Strittmatter; Thomas Wisniewski
Journal:  BMC Neurosci       Date:  2010-10-14       Impact factor: 3.288

8.  Stably maintained dendritic spines are associated with lifelong memories.

Authors:  Guang Yang; Feng Pan; Wen-Biao Gan
Journal:  Nature       Date:  2009-11-29       Impact factor: 49.962

9.  Prion protein-mediated toxicity of amyloid-β oligomers requires lipid rafts and the transmembrane LRP1.

Authors:  Jo V Rushworth; Heledd H Griffiths; Nicole T Watt; Nigel M Hooper
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

10.  Experience leaves a lasting structural trace in cortical circuits.

Authors:  Sonja B Hofer; Thomas D Mrsic-Flogel; Tobias Bonhoeffer; Mark Hübener
Journal:  Nature       Date:  2008-11-12       Impact factor: 49.962

View more
  12 in total

1.  Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.

Authors:  Santiago V Salazar; Timothy O Cox; Suho Lee; A Harrison Brody; Annabel S Chyung; Laura T Haas; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2018-12-05       Impact factor: 6.167

2.  Pyk2 Signaling through Graf1 and RhoA GTPase Is Required for Amyloid-β Oligomer-Triggered Synapse Loss.

Authors:  Suho Lee; Santiago V Salazar; Timothy O Cox; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

Review 3.  Cellular prion protein as a receptor for amyloid-β oligomers in Alzheimer's disease.

Authors:  Santiago V Salazar; Stephen M Strittmatter
Journal:  Biochem Biophys Res Commun       Date:  2016-09-14       Impact factor: 3.575

4.  Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network.

Authors:  Hideyuki Takahashi; Zoe A Klein; Sarah M Bhagat; Adam C Kaufman; Mikhail A Kostylev; Tsuneya Ikezu; Stephen M Strittmatter
Journal:  Acta Neuropathol       Date:  2017-01-09       Impact factor: 17.088

5.  Conditional Deletion of Prnp Rescues Behavioral and Synaptic Deficits after Disease Onset in Transgenic Alzheimer's Disease.

Authors:  Santiago V Salazar; Christopher Gallardo; Adam C Kaufman; Charlotte S Herber; Laura T Haas; Sophie Robinson; Jean C Manson; Michael K Lee; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

6.  Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer's Mouse Phenotypes.

Authors:  Laura T Haas; Santiago V Salazar; Levi M Smith; Helen R Zhao; Timothy O Cox; Charlotte S Herber; Andrew P Degnan; Anand Balakrishnan; John E Macor; Charles F Albright; Stephen M Strittmatter
Journal:  Cell Rep       Date:  2017-07-05       Impact factor: 9.423

Review 7.  Animal Models of Psychosis in Alzheimer Disease.

Authors:  Josh M Krivinko; Jeremy Koppel; Alena Savonenko; Robert A Sweet
Journal:  Am J Geriatr Psychiatry       Date:  2019-05-17       Impact factor: 4.105

8.  Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q.

Authors:  Joshua Spurrier; LaShae Nicholson; Xiaotian T Fang; Austin J Stoner; Takuya Toyonaga; Daniel Holden; Timothy R Siegert; William Laird; Mary Alice Allnutt; Marius Chiasseu; A Harrison Brody; Hideyuki Takahashi; Sarah Helena Nies; Azucena Pérez-Cañamás; Pragalath Sadasivam; Supum Lee; Songye Li; Le Zhang; Yiyun H Huang; Richard E Carson; Zhengxin Cai; Stephen M Strittmatter
Journal:  Sci Transl Med       Date:  2022-06-01       Impact factor: 19.319

Review 9.  Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.

Authors:  A Harrison Brody; Stephen M Strittmatter
Journal:  Adv Pharmacol       Date:  2017-10-25

10.  Increased BBB Permeability Enhances Activation of Microglia and Exacerbates Loss of Dendritic Spines After Transient Global Cerebral Ischemia.

Authors:  Furong Ju; Yanli Ran; Lirui Zhu; Xiaofeng Cheng; Hao Gao; Xiaoxia Xi; Zhanli Yang; Shengxiang Zhang
Journal:  Front Cell Neurosci       Date:  2018-08-03       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.